Answers are grounded in this paper and cite their sources.
Background Staged micrographic excision (SME) offers complete peripheral margin assessment; lower recurrence rates compared to wide local excision (WLE) have been reported in the literature. Still, evidence for the management of malignant melanoma (MM) in sub-Saharan Africa with SME is limited. Objective To evaluate recurrence rates, surgical outcomes, and patient satisfaction following SME for MM in South Africa. Methods A retrospective review of 362 patients treated with SME for MM was conducted. Incidence of recurrence was calculated in person-years, and follow-up data were collected. Results Of 362 cases, 74.2% were malignant melanoma in situ (MMIS) and 25.8% invasive MM, predominantly on the head and neck (55.8%). Most lesions (82.2%) were excised in a single stage, with mean margins of 7.6 mm for MMIS and 11.7 mm for invasive MM. Median Breslow depth was 0.54 mm, and sentinel lymph node biopsy was performed in 5.1% of cases. Only two recurrences (0.55%) occurred, no significant associations were found. Patient satisfaction was high (98%). Limitations This study, with a predominance of early-stage melanomas and no comparator group, limits generalisability and interpretation of the low observed recurrence. Incomplete follow-up and non-validated, variably timed satisfaction assessments introduce potential selection, recall, and response bias. Conclusion This is the first South African series reporting on SME for MM, describing a low observed recurrence rate (0.55%) in a predominantly early-stage melanoma cohort.
No takes yet. Share an insight, caveat, or question.
Smit et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: